SMS Lifesciences India Ltd. | Small-cap | Healthcare
₹1,172.20
-0.48%
| SMS Lifesciences Stock Comparison:
No comparison data available
Overview Income Statement Balance Sheet Cash Flow Key Ratios

Financial Overview

Latest Annual: 2025

Income Metrics

Revenue 3.4B
Gross Profit 1.3B 36.29%
Operating Income 300.4M 8.71%
Net Income 187.3M 5.43%
EPS (Diluted) ₹66.51

Balance Sheet Metrics

Total Assets 3.9B
Total Liabilities 1.8B
Shareholders Equity 2.1B
Debt to Equity 0.84

Cash Flow Metrics

Operating Cash Flow 289.7M
Free Cash Flow 187.1M

Revenue & Profitability Trend

SMS Lifesciences Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue 3.4B 3.0B 3.1B 3.5B 2.6B
Cost of Goods Sold 2.2B 2.1B 2.3B 2.6B 1.9B
Gross Profit 1.3B 907.7M 845.5M 875.4M 702.1M
Operating Expenses 205.4M 135.8M 122.1M 128.1M 149.8M
Operating Income 300.4M 162.8M 180.5M 246.5M 223.9M
Pre-tax Income 261.9M 98.5M 165.9M 327.3M 195.7M
Income Tax 74.6M 35.2M 52.2M 74.3M 60.1M
Net Income 187.3M 63.3M 113.8M 253.0M 135.6M
EPS (Diluted) ₹66.51 ₹30.08 ₹37.92 ₹83.76 ₹44.84

Income Statement Trend

SMS Lifesciences Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets 1.5B 1.6B 1.6B 1.6B 1.3B
Non-Current Assets 2.4B 2.4B 2.4B 2.0B 1.8B
Total Assets 3.9B 3.9B 3.9B 3.6B 3.0B
Liabilities
Current Liabilities 1.4B 1.4B 1.3B 1.4B 1.1B
Non-Current Liabilities 358.8M 523.2M 731.1M 563.8M 590.0M
Total Liabilities 1.8B 2.0B 2.1B 1.9B 1.7B
Equity
Total Shareholders Equity 2.1B 1.9B 1.9B 1.6B 1.3B

Balance Sheet Composition

SMS Lifesciences Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income 261.9M 98.5M 142.4M 200.4M 195.7M
Operating Cash Flow 289.7M 124.7M 251.1M -320.5M 151.3M
Investing Activities
Capital Expenditures -149.8M -207.4M -428.0M -415.2M -354.7M
Investing Cash Flow -150.6M -185.3M -314.9M -73.5M -266.2M
Financing Activities
Dividends Paid -4.5M -4.5M -4.5M - -
Financing Cash Flow -142.0M -14.3M 208.9M 130.4M -2.5M
Free Cash Flow 187.1M 34.4M -338.6M -623.9M -3.9M

Cash Flow Trend

SMS Lifesciences Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 17.78
Price to Book 1.82
Price to Sales 1.04
PEG Ratio 0.15

Profitability Ratios

Profit Margin 5.83%
Operating Margin 4.07%
Return on Equity 9.24%
Return on Assets 4.81%

Financial Health

Current Ratio 1.06
Debt to Equity 40.75
Beta 0.37

Per Share Data

EPS (TTM) ₹66.56
Book Value per Share ₹649.96
Revenue per Share ₹1,140.16

Financial data is updated regularly. All figures are in the company's reporting currency.